Search
ImageneBio Ord Shs
IMAAdd to Watchlist
4.840USD
-0.010-0.21%
Close 09-23 16:00（ET）
54.60MMarket Cap
LossP/E TTM
ImageneBio Ord Shs (IMA) Stock Price Target & Forecast
Analyst Rating
Based on 4 analysts
Buy
2 Strong Buy
1 Buy
0 Hold
0 Sell
1 Strong Sell
Target Price
18.000USD+271.13%
IMA Analyst Recommendation Trends
In the current month, IMA has received 1 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. IMA average Analyst price target in the last month is 18.000.
2026-09
2026-08
2026-07
2026-06
2026-05
2026-04
2026-03
2026-02
2
2
2
2
2
2
2
2
1
1
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1
1
1
1
1
1
1
1
0
0
0
0
0
0
0
0
4
4
3
3
3
3
3
3
IMA Analyst Rating for Peer Comparison
Updated: Sep 23, 2026Company name
Strong Buy
Buy
Hold
Sell
Strong Sell
Analysts
Beigene Ltd
ONC
8
19
0
1
0
28
Ionis Pharmaceuticals Inc
IONS
6
14
6
0
0
26
argenx SE
ARGX
10
13
3
0
0
26
IQVIA Holdings Inc
IQV
8
12
4
0
0
24
Insmed Inc
INSM
7
17
0
0
0
24
Kymera Therapeutics Inc
KYMR
9
12
2
0
0
23
CRISPR Therapeutics AG
CRSP
4
8
10
0
0
22
Revolution Medicines Inc
RVMD
8
13
1
0
0
22
Cytokinetics Inc
CYTK
4
16
2
0
0
22
Tempus AI Inc
TEM
5
6
7
1
1
20
Financial Forecasting
Based on analysts' estimates, IMA EPS is projected to reach -0.805 in FY2026Q3, following reported EPS of -0.630 in FY2026Q2. Track earnings expectations against reported figures to see how profitability is evolving.
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
FY2025Q4
FY2026Q1
FY2026Q2
FY2026Q3
FY2026Q4
Forecast
-1.45
-0.70
-0.90
-0.81
-0.92
Actual
-0.86
-0.95
-0.63
--
--
Surprise
+40.73%
-34.64%
+29.64%
--
--
FAQs
What is ImageneBio Ord Shs's price target?
Analysts forecast that ImageneBio Ord Shs's price target is USD 18.00, with the highest forecast at USD 28.00 and the lowest forecast at USD 2.00.
How have ImageneBio Ord ShsIMA's recent earnings per share performed?
The market expectation was USD -0.63, while ImageneBio Ord ShsIMA's earnings per share (EPS) for the previous quarter was USD -0.95. EPS for the next quarter is expected at USD -0.81.
What is the analyst rating for ImageneBio Ord Shs?
Based on the ratings of ImageneBio Ord Shs's stock from 4 analysts, most analysts support a Buy trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as Buy. Please note that this is not trading advice. You still need to conduct your own analysis.